Israel Alfassi - Net Worth and Insider Trading

Israel Alfassi Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Israel Alfassi owns 2 companies in total, including Artemis Therapeutics Inc (ATMS) , and Manuka Inc (MNKA) .

Click here to see the complete history of Israel Alfassi’s form 4 insider trades.

Insider Ownership Summary of Israel Alfassi

Ticker Comapny Transaction Date Type of Owner
ATMS Artemis Therapeutics Inc 2016-08-23 director
MNKA Manuka Inc 2016-08-23 director

Israel Alfassi Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Israel Alfassi Ownership Network

Ownership Network List of Israel Alfassi

No Data

Ownership Network Relation of Israel Alfassi

Insider Network Chart

Israel Alfassi Owned Company Details

What does Artemis Therapeutics Inc do?

Who are the key executives at Artemis Therapeutics Inc?

Israel Alfassi is the director of Artemis Therapeutics Inc. Other key executives at Artemis Therapeutics Inc include Chief Financial Officer David Dana , director & Chief Executive Officer Shimon Citron , and Chief Executive Officer Brian M Culley .

Artemis Therapeutics Inc (ATMS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Artemis Therapeutics Inc (ATMS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Artemis Therapeutics Inc (ATMS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Artemis Therapeutics Inc (ATMS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Artemis Therapeutics Inc Insider Transactions

No Available Data

Israel Alfassi Mailing Address

Above is the net worth, insider trading, and ownership report for Israel Alfassi. You might contact Israel Alfassi via mailing address: 18 East 16th Street, Suite 307, New York Ny 10003.

Discussions on Israel Alfassi

No discussions yet.